top of page
Health Integrated Western and Chinese Medicine Centre
Meningococcal Quadrivalent Vaccines(Nimenrix)
6 weeks or above
Nimenrix
Provider:
PRIZER
Certification:
EMA & Hong Kong Department of Health
Suggested age:
6 weeks or above
Disease Prevention:
Meningococcal quadrivalent vaccines protect against 4 types of meningococcal bacteria: types A, C, Y and W-135.
Side Effect:
Soreness, redness and swelling where the vaccine was given.
Interval:
2, 4, 12 months old: 3 dose
3, 5, 12 months old: 3 dose
12 months old: 1 dose
Precautions:
/
bottom of page